Optimizing Early-Stage Oncology: TFS’s Strategic Approach to a Dose Escalation and Expansion Phase I Trial

Discover how a U.S. biotech company partnered with TFS HealthScience to manage a Phase I oncology trial for a new treatment targeting advanced epithelial tumors. The collaboration covered regulatory consulting, site identification, clinical monitoring, and other services to optimize dose escalation and expansion phases. TFS’s expertise streamlined operations, ensuring efficiency and adherence to regulatory standards.

What You’ll Learn:

  • How a specialized study team handles seamless trial execution & complex procedures effectively
  • The importance of proactive site selection, including a backup site, for enrollment speed & risk reduction
  • How prompt data reviews & safety updates allow for timely recruitment & study completion
  • The impact of skillful management on slot allocation, patient tracking, & data cleaning

Learn more about our related services and resources:

TFS Oncology & Hematology

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology & Hematology Expertise

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to KnowArticle

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know

Explore key takeaways from ASCO 2025, from ctDNA and AI to novel biologics and inclusive trials. Learn how to stay ahead in oncology research.
Revolutionizing-Oncology-Trials-The-Power-of-Immunotherapy-and-Precision-Medicine-in-Cancer-Research_featured
Revolutionizing Oncology Trials: The Power of Immunotherapy and Precision Medicine in Cancer ResearchArticle

Revolutionizing Oncology Trials: The Power of Immunotherapy and Precision Medicine in Cancer Research

A comprehensive guide exploring the challenges and best practices in cancer immunotherapy clinical trials.
Next-Generation-Oncology-Research-How-CROs-Are-Accelerating-Cancer-Drug-Development_featured
Next-Generation Oncology Research: How CROs Are Accelerating Oncology Drug DevelopmentArticle

Next-Generation Oncology Research: How CROs Are Accelerating Oncology Drug Development

See how next-gen CROs leverage AI, digital biomarkers, & trial designs to accelerate oncology drug development & regulatory approval.